Wednesday, November 13, 2024
HomeTagsBiotechnology

Biotechnology

Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced that it has secured a €4.3 million non-dilutive financing...

Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst...

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...

Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)

Puma Biotechnology, Inc. a biopharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) issued a Patent Term Extension Certificate for U.S....

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it entered into...

Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine

Red Cell Partners (“Red Cell”), an investment and incubation firm that backs, builds, and scales technology-led companies in healthcare and defense, today announced the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics